This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Read More

Prefilled Syringes Drug Molecules Market

Prefilled Syringes Drug Molecules Market by Drug Class (Vaccines, Insulin, Adrenaline, Opioids, Others), Application (Cardiovascular Diseases, Diabetes, Immunization, Pain Management, Others), End User (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores) & Region – Forecast 2022 – 2028

Prefilled Syringes Drug Molecules Market by Drug Class (Vaccines, Insulin, Adrenaline, Opioids, Others), Application (Cardiovascular Diseases, Diabetes, Immunization, Pain Management, Others), End User (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores) & Region – Forecast 2022 – 2028

Prefilled Syringes Drug Molecules Market - Analysis, Outlook, Growth, Trends, Forecasts

Prefilled Syringes Drug Molecules Market Outlook (2022-2028)

[306 Pages Report] The global Prefilled Syringes Drug Molecules Market is set to be valued at US$ 56 Bn in 2022, and is projected to expand at a CAGR of 5.6% to close in on a valuation of US$ 77.7 Bn by 2028.

Prefilled Syringes Drug Molecules Market Size (2022)

US$ 56 Bn

Prefilled Syringes Drug Molecules Sales Forecast (2028)

US$ 77.7 Bn

Global Market Growth Rate (2022 to 2028)

5.6% CAGR

Share of Top 5 Prefilled Syringes Drug Molecules Providers

55%

At present, sales of prefilled syringes drug molecules account for around 23% market share of the global drug delivery market. Demand for prefilled syringes drug molecules in online pharmacies is likely to increase at a CAGR of 6.2% over the assessment period of 2022 to 2028.

Prefilled Syringes Drug Molecules Consumption Analysis (2012-2021) in Comparison to Market Outlook (2022-2028)

The global prefilled syringes drug molecules market witnessed a growth rate of 5.3% over the historical period of 2012 to 2028.

Prefilled syringes drug delivery is preferred over conventional vials as it comes with various benefits such as less over-filling as well as safe and convenient use, thus driving demand for prefilled syringes drug molecules.

Prefilled syringes drug delivery is convenient for those patients that require parenteral administration of drugs on a daily/weekly basis and long-term treatment. As such, they prefer self-administrated devices as they don’t have to remain dependent on doctors for each dosage.

Prefilled syringes provide inexpensive home setting medication and reduce time consumed at in-patient and out-patient care units. For patients requiring frequent dose administration on a weekly and daily basis, use of prefilled syringes drug molecules reduces the average cost per injection when compared to vials and ampoules.

There is also a decrease in the reliance on healthcare professionals in many regions, and this is likely to boost the small molecule prefilled syringes market. Revenue growth of the market is mainly driven by the effectiveness, convenience, and ease of use of prefilled syringes. This has attracted various healthcare professionals and patients to use prefilled syringe products.

In addition, the minimal contamination of drug molecules and self-administration of drugs at home settings has increased demand for prefilled syringes drug molecules. Prefilled syringe manufacturers are focusing on introducing updated technologies and advanced prefilled syringe products to attract more customers.

Pharmaceutical companies are introducing generic versions for cost-effective auto-injector devices, and are targeting emerging regions to sustain and grow in the global prefilled syringes drug molecules market.

Overall, the global prefilled syringes drug molecules market is slated to surge at a CAGR of 5.6% from 2022 to 2028.

What Makes North America the Largest Regional Market for Prefilled Syringes Drug Molecules?

On the basis of region, North America is expected to lead the global market for prefilled syringes drug molecules. The North American regional market is expected to account for 30.6% share in 2022, closely followed by Western Europe.

Rising need for self-administered equipment for patients' regular prescription doses, breakthroughs in technology, well-developed pharmaceutical system, and growing adoption of auto-injector devices are driving market growth in the region.

Prefilled syringe manufacturers are being compelled to develop cost-effective auto-injector devices as a result of increased global investments in healthcare development, greater disposable income, and improving standard of life.

Country-wise Analysis

How is the U.S. Prefilled Syringes Drug Molecules Market Faring?

The U.S. prefilled syringes drug molecules market is flourishing as a result of rising lifestyle-related disorders and the growing desire for easy-to-administer injectables among chronic disease patients.

In the market, there is a huge concentration of vendors who sell both, end products and original components. Availability of qualified vendors ensures high usage of prefilled syringes in the United States.

Will Manufacturers of Prefilled Syringes Drug Molecules Gain Profits in China?

Increased pharmaceutical development, ageing population, healthcare innovations, and the highest number of diabetic patients are factors driving prefilled syringes drug molecules demand growth in China.

Prefilled syringe providers are concentrating their efforts in China to strengthen their positions in the global market. This is one of the areas where China is projected to see significant growth in the next few years.

Furthermore, China is predicted to rise significantly in the market over the forecast period as a result of market participants expanding their businesses by investing in new manufacturing facilities.

Category-wise Insights

Which Drug Class Will Hold Maximum Sway in Prefilled Syringes Drug Molecules?

On the basis of drug class, vaccines are anticipated to register the highest CAGR over the forecast period. Sales of vaccines are projected to increase 2.1X by 2028.

Vaccines are antigenic substances prepared from the causative agent of a disease or a synthetic substitute, used to provide immunity against one or several diseases. Vaccines stimulate the immune system to make antibodies in the same way that it does when a person is exposed to a disease.

Vaccination is a simple, safe, and efficient technique to protect oneself from deadly diseases before they infect. It strengthens the immune system by utilizing the body's own defences to create resistance to specific pathogens.

Due to the rapid production of coronavirus vaccines, the impact of COVID-19 on pharmaceutical packaging is projected to be significant. Growing adoption of prefilled syringes for vaccination purposes is set to fueling prefilled syringes drug molecules consumption over the coming years.

Which End User of Prefilled Syringes Drug Molecules Will Emerge as a Key Market Contributor?

In terms of end users, sales of prefilled syringes drug molecules through online pharmacies is projected to register a high growth rate of 6.2% over the forecast period.

Growing trend of self-care, which is fueled by the easy availability of technological gadgets that lessen the need for visits to healthcare professionals, is likely to stifle the growth of hospital pharmacies. Furthermore, online pharmacies assist individuals with chronic illnesses such as diabetes and allergies.

Patients who need to take regular injection doses prefer to get their prescriptions from online order pharmacies. This assists in lowering the total cost to the patient during the course of treatment. Products offered through online pharmacies must be created with the patient's comfort in mind.

Impact of COVID-19 on Prefilled Syringes Drug Molecules Demand Growth

The COVID-19 pandemic and subsequent lockdowns in several nations throughout the world have had a financial impact on enterprises in all sectors, including the healthcare sector.

The COVID-19 pandemic, which began in 2020, affected healthcare delivery all around the world, including delays in the needle or syringe-related diagnosis and treatment. As a result, the impact of COVID-19 restricted the growth of the global prefilled syringes drug molecules market. The pandemic has had an influence on the market, and the impact of the pandemic on medicine manufacturing and supply chain is projected to have a short-term impact on the market.

Because of the lower danger of needle-stick injuries, prefilled syringes are becoming more popular than glass ampoules or any other additional needles. As a result, producers are increasing their production capacity in order to scale up the production of the COVID-19 vaccine. Demand for prefilled syringe products has increased as a result of the COVID-19 pandemic.

Competitive Landscape

The global prefilled syringes drug molecules market is highly competitive due to the presence of well-established top players. However, prefilled syringes drug molecules brands such as EpiPen auto-injector and BD Physioject disposable auto-injector have strategically maintained their position in the market owing to a distinctive value proposition such as providing more precision and accurate dosages.

For instance,

  • In December 2020, BD (Becton, Dickinson and Company) decided to invest approximately US$ 1.2 Bn over the next four years to broaden and enhance its production capabilities and innovation for pre-fillable syringes (PFS) and advanced drug delivery systems (ADDS) throughout its six global production sites, as well as to open a new assembly plant in Spain.

Prefilled Syringes Drug Molecules Industry Report Scope

Attribute

Details

Forecast Period

2022-2028

Historical Data Available for

2012-2021

Market Analysis

Value in US$ Mn

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa (MEA)

Key Countries Covered

  • U.S.
  • Canada
  • Mexico
  • Brazil
  • Mexico
  • Argentina
  • Germany
  • Italy
  • France
  • U.K
  • Nordic
  • Spain
  • Japan
  • China
  • India
  • Malaysia
  • Thailand
  • Australia
  • GCC Countries
  • South Africa
  • Turkey

Key Market Segments Covered

  • Drug Class
  • Application
  • End User
  • Region

Key Companies Profiled

  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • AstraZeneca plc
  • Mylan N.V.
  • Pfizer, Inc.
  • Fresenius Kabi AG
  • Johnson & Johnson
  • Sanofi
  • Merck & Co. Inc.
  • Novartis AG
  • McKesson Corporation

Pricing

Available upon Request

Sign Up with MarketNgage

World's Most Profilic Intelligence Engine

Get Access To The World's Largest Market Research Database.

Sign Up Now

Key Segments of Prefilled Syringes Drug Molecules Industry Research

By Drug Class :

  • Vaccines
  • Insulin
  • Adrenaline
  • Opioids
  • Others

By Application :

  • Prefilled Syringes Drug Molecules for Cardiovascular Diseases
  • Prefilled Syringes Drug Molecules for Diabetes
  • Prefilled Syringes Drug Molecules for Immunization
  • Prefilled Syringes Drug Molecules for Pain Management
  • Others

By End User :

  • Prefilled Syringes Drug Molecules Sold at Hospital Pharmacies
  • Prefilled Syringes Drug Molecules Sold at Retail Pharmacies
  • Prefilled Syringes Drug Molecules Sold through Online Pharmacies
  • Prefilled Syringes Drug Molecules Sold at Drug Stores

By Region :

  • North America Prefilled Syringes Drug Molecules Market
  • Latin America Prefilled Syringes Drug Molecules Market
  • Europe Prefilled Syringes Drug Molecules Market
  • East Asia Prefilled Syringes Drug Molecules Market
  • South Asia & Pacific Prefilled Syringes Drug Molecules Market
  • Middle East & Africa (MEA) Prefilled Syringes Drug Molecules Market

Key Questions Answered in the Report

How much is the prefilled syringes drug molecules market worth?

The global prefilled syringes drug molecules market is currently valued at around US$ 56 Bn.
Rising self-medication and digitalization as well as lower costs and increased efficiency of prefilled syringes are driving market growth.
North America is the largest and fastest-growing regional market for prefilled syringes drug molecules at an expected CAGR of 6.2% over the forecast period.
Amgen Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Mylan N.V., and Pfizer, Inc. are identified as leading providers of prefilled syringes drug molecules.
Vaccines account for 50% share of the prefilled syringes drug molecules industry.
The global prefilled syringes drug molecules market is expected to exhibit a CAGR of 5.6% over the forecast period (2022-2028).

Need specific information?

Our Clients

Healthcare

View All Reports from Healthcare

View Reports

Recommendations

Healthcare

Implantable Drug Eluting Devices Market

Published : 2019-11-13

Healthcare

Radiation Toxicity Treatment Market

Published : 2019-12-12

Healthcare

Instrument Cleaners And Detergents Market

Published : 2021-05-24

Healthcare

Animal Artificial Insemination Market

Published : 2021-06-14